About: Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2007 (uk) im August 2007 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'agostu de 2007 (ast) scientific article published on 01 August 2007 (en)
publication date	wds:Q81160948-B3674E1C-164C-49D0-9479-14E6254EB79D
publication date	2007-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q81160948-6F7B5A47-637B-4A99-BFE3-AD643171C077
language of work or name	English
cites work	wds:Q81160948-67533555-D1F9-414F-98B9-5FAD49CD5E84 wds:Q81160948-7CCEC976-C2F1-45E9-A631-B7DA78F543FA wds:Q81160948-917D8807-D72A-4EA9-AABE-BF49092CFE0F wds:Q81160948-942F449B-11D4-4BD5-A44F-3287F8C54F0C wds:Q81160948-A061A5CC-B84C-488C-80C7-F739A0ED8299 wds:Q81160948-CB009504-21D5-480E-A852-A28083AC18BA wds:Q81160948-D632C833-F5D0-4F57-8948-028306CC57B7 wds:Q81160948-EA4265ED-1015-4EDF-85EB-2162028CA691
cites work	Computed tomography characterization of renal cell tumors in correlation with histopathology Expression of prostate-specific membrane antigen in normal and malignant human tissues Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen Technology insight: monoclonal antibody imaging of prostate cancer The current role of angiogenesis inhibitors in the treatment of renal cell carcinoma Molecular expression of PSMA mRNA and protein in primary renal tumors. Molecular genetics of familial renal cell carcinoma syndromes Blood-based RT-PCR assays of MN/CA9 or PSMA: clinical application in renal cancer patients
author name string	wds:Q81160948-B34401F9-0485-4A20-AE98-5AE571093FA9 wds:Q81160948-BA5F6B9D-3893-4D3E-9F27-806688662F54 wds:Q81160948-CF90AB63-A915-4E5E-B99D-74A87655DC51 wds:Q81160948-E9EDFDE4-1919-43A7-B450-75A0A2694309 wds:Q81160948-FAE8212F-544A-4489-B01F-B91C84A46B5C
author name string	Ming Zhou Warren Heston Jianbo Li Linda Sercia Angelo Baccala
rdfs:label	Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms (en) Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms (nl)
skos:prefLabel	Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms (en) Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms (nl)
name	Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms (en) Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms (nl)
title	wds:Q81160948-4C5B45FE-0A61-4DC5-A38E-D254A0F1F585
title	Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms (en)
page(s)	wds:Q81160948-3ECE0598-55F3-4D4D-B318-06118BB8D3C1
page(s)	385-390
instance of	wds:Q81160948-BD29B7B3-BD14-48EA-A81D-A66188081A54
instance of	scholarly article
PubMed ID	wds:Q81160948-A4220110-6B2E-4C2A-9843-0EC00D6ABC90
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17826525
PubMed ID	17826525
published in	wds:Q81160948-FB0ACABB-E8D6-4C7A-AD52-CCE33371A1E5
published in	Urology
issue	wds:Q81160948-09C63042-1F00-4228-A2F0-B08BB08C873D
volume	wds:Q81160948-DBD9C60A-D97D-469A-995C-0E1EBCE6C1F6
issue	2
volume	70
DOI	wds:Q81160948-9867163D-1F1C-4477-8EE3-D8094291D8F7
DOI	http://dx.doi.org/10.1016/J.UROLOGY.2007.03.025
DOI	10.1016/J.UROLOGY.2007.03.025
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q81160948
is cites work of	Prodrug strategy for PSMA-targeted delivery of TGX-221 to prostate cancer cells Expression of prostate-specific membrane antigen in lung cancer cells and tumor neovasculature endothelial cells and its clinical significance Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen A low molecular weight PSMA-based fluorescent imaging agent for cancer Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatments PSMA expression in Schwannoma: a potential clinical mimicker of metastatic prostate carcinoma Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted ¹⁸F-DCFPyL PET/CT. The prostate-specific membrane antigen: lessons and current clinical implications from 20 years of research (68)Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma. Targeted alpha therapy of mCRPC: Dosimetry estimate of 213Bismuth-PSMA-617. Reduction of 68Ga-PSMA renal uptake with mannitol infusion: preliminary results. Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors. Low level endogenous prostate-specific membrane antigen (PSMA) expression in non-prostatic tumor xenografts is sufficient for in vivo tumor targeting and imaging. PSMA expression by microvasculature of thyroid tumors - Potential implications for PSMA theranostics Prostate-specific membrane antigen as a target for cancer imaging and therapy High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity. PSMA-Targeted 18F-DCFPyL PET/CT Imaging of Clear Cell Renal Cell Carcinoma: Results from a Rapid Autopsy Low levels of PSMA expression limit the utility of 18F-DCFPyL PET/CT for imaging urothelial carcinoma. Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases. Expression of Prostate-Specific Membrane Antigen in Tumor-Associated Vasculature Predicts Poor Prognosis in Hepatocellular Carcinoma Pilot study: use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumour. Detection of 18F-FDG PET/CT Occult Lesions With 18F-DCFPyL PET/CT in a Patient With Metastatic Renal Cell Carcinoma Diagnostic potential of PET/CT using a 68Ga-labelled prostate-specific membrane antigen ligand in whole-body staging of renal cell carcinoma: initial experience. Nuclear imaging of renal tumours: a step towards improved risk stratification Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives. Preclinical Comparative Study of (68)Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA. Dosimetry of Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST Protocol Why Targeting PSMA Is a Game Changer in the Management of Prostate Cancer. Advanced Molecular Imaging in Histologically Verified Metanephric Adenoma Renal Cell Carcinoma: the Oncologist Asks, Can PSMA PET/CT Answer? Molecular imaging in drug development: Update and challenges for radiolabeled antibodies and nanotechnology. Pitfalls in Gallium-68 PSMA PET/CT Interpretation-A Pictorial Review Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancer 68Ga-dotatoc vs. 18F-FDG vs. radiolabelled PSMA PET/CT in renal cancer patients New frontiers in prostate cancer imaging: clinical utility of prostate-specific membrane antigen positron emission tomography. Kidney cancer: PSMA: a potential therapeutic target in RCC. Imaging for Metastatic Renal Cell Carcinoma Prostate specific membrane antigen (PSMA) expression in vena cava tumour thrombi of clear cell renal cell carcinoma suggests a role for PSMA-driven tumour neoangiogenesis Prostate-specific Membrane Antigen Based Antibody-drug Conjugates for Metastatic Castration-resistance Prostate Cancer

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software